APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diammonium Glycyrrhizinate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Diammonium Glycyrrhizinate Market Analysis and Forecast 2026-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchDiammonium Glycyrrhizinate Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Diammonium Glycyrrhizinate Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Diammonium Glycyrrhizinate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diammonium Glycyrrhizinate Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Diammonium Glycyrrhizinate Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Diammonium Glycyrrhizinate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Diammonium Glycyrrhizinate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Diammonium Glycyrrhizinate include Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd, Suzhou Erye Pharmaceutical Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd, Jiangsu Tiansheng Pharmaceutical Co. Ltd, Sinopharm Guorui Pharmaceutical Co. Ltd and ND Pharma & Biotech Co. Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Diammonium Glycyrrhizinate, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Diammonium Glycyrrhizinate, also provides the revenue of main regions and countries. Of the upcoming market potential for Diammonium Glycyrrhizinate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diammonium Glycyrrhizinate revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Diammonium Glycyrrhizinate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Diammonium Glycyrrhizinate revenue, projected growth trends, production technology, application and end-user industry.

Diammonium Glycyrrhizinate Segment by Company

Chia Tai Tianqing Pharmaceutical Group Co. Ltd

Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd

Suzhou Erye Pharmaceutical Co. Ltd

Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd

Jiangsu Tiansheng Pharmaceutical Co. Ltd

Sinopharm Guorui Pharmaceutical Co. Ltd

ND Pharma & Biotech Co. Ltd.

Diammonium Glycyrrhizinate Segment by Type

Injection

Capsule

Diammonium Glycyrrhizinate Segment by Application

Chronic Viral Hepatitis

Immune Regulation

Diammonium Glycyrrhizinate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diammonium Glycyrrhizinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diammonium Glycyrrhizinate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diammonium Glycyrrhizinate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Diammonium Glycyrrhizinate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Diammonium Glycyrrhizinate company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diammonium Glycyrrhizinate revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Diammonium Glycyrrhizinate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Player Table 3. Capsule Major Player Table 4. Global Diammonium Glycyrrhizinate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Chronic Viral Hepatitis Major Player Table 6. Immune Regulation Major Player Table 7. Diammonium Glycyrrhizinate Industry Trends Table 8. Diammonium Glycyrrhizinate Industry Drivers Table 9. Diammonium Glycyrrhizinate Industry Opportunities and Challenges Table 10. Diammonium Glycyrrhizinate Industry Restraints Table 11. Global Diammonium Glycyrrhizinate Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Diammonium Glycyrrhizinate Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Diammonium Glycyrrhizinate Market Share by Region (2021-2026) Table 14. Global Diammonium Glycyrrhizinate Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Diammonium Glycyrrhizinate Market Share by Region (2027-2032) Table 16. Global Diammonium Glycyrrhizinate Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Diammonium Glycyrrhizinate Revenue Market Share by Players (2021-2026) Table 18. Global Diammonium Glycyrrhizinate Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Diammonium Glycyrrhizinate Key Players Headquarters & Area Served Table 20. Global Diammonium Glycyrrhizinate Players, Product Type & Application Table 21. Global Diammonium Glycyrrhizinate Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Diammonium Glycyrrhizinate by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Diammonium Glycyrrhizinate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Diammonium Glycyrrhizinate Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Diammonium Glycyrrhizinate Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Diammonium Glycyrrhizinate Revenue Market Share by Type (2021-2026) Table 28. Global Diammonium Glycyrrhizinate Revenue Market Share by Type (2027-2032) Table 29. Global Diammonium Glycyrrhizinate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Diammonium Glycyrrhizinate Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Diammonium Glycyrrhizinate Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Diammonium Glycyrrhizinate Revenue Market Share by Application (2021-2026) Table 33. Global Diammonium Glycyrrhizinate Revenue Market Share by Application (2027-2032) Table 34. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Company Information Table 35. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Business Overview Table 36. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 38. Chia Tai Tianqing Pharmaceutical Group Co. Ltd Recent Development Table 39. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Company Information Table 40. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Business Overview Table 41. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 43. Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Recent Development Table 44. Suzhou Erye Pharmaceutical Co. Ltd Company Information Table 45. Suzhou Erye Pharmaceutical Co. Ltd Business Overview Table 46. Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 48. Suzhou Erye Pharmaceutical Co. Ltd Recent Development Table 49. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Company Information Table 50. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Business Overview Table 51. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Product Portfolio Table 53. Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Recent Development Table 54. Jiangsu Tiansheng Pharmaceutical Co. Ltd Company Information Table 55. Jiangsu Tiansheng Pharmaceutical Co. Ltd Business Overview Table 56. Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 58. Jiangsu Tiansheng Pharmaceutical Co. Ltd Recent Development Table 59. Sinopharm Guorui Pharmaceutical Co. Ltd Company Information Table 60. Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview Table 61. Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio Table 63. Sinopharm Guorui Pharmaceutical Co. Ltd Recent Development Table 64. ND Pharma & Biotech Co. Ltd. Company Information Table 65. ND Pharma & Biotech Co. Ltd. Business Overview Table 66. ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Product Portfolio Table 68. ND Pharma & Biotech Co. Ltd. Recent Development Table 69. North America Diammonium Glycyrrhizinate Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Diammonium Glycyrrhizinate Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Diammonium Glycyrrhizinate Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Diammonium Glycyrrhizinate Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Diammonium Glycyrrhizinate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Diammonium Glycyrrhizinate Revenue by Country (2021-2026) & (US$ Million) Table 75. North America Diammonium Glycyrrhizinate Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe Diammonium Glycyrrhizinate Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe Diammonium Glycyrrhizinate Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe Diammonium Glycyrrhizinate Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe Diammonium Glycyrrhizinate Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe Diammonium Glycyrrhizinate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Diammonium Glycyrrhizinate Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe Diammonium Glycyrrhizinate Revenue by Country (US$ Million) & (2027-2032) Table 83. China Diammonium Glycyrrhizinate Revenue by Type (2021-2026) & (US$ Million) Table 84. China Diammonium Glycyrrhizinate Revenue by Type (2027-2032) & (US$ Million) Table 85. China Diammonium Glycyrrhizinate Revenue by Application (2021-2026) & (US$ Million) Table 86. China Diammonium Glycyrrhizinate Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Diammonium Glycyrrhizinate Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia Diammonium Glycyrrhizinate Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia Diammonium Glycyrrhizinate Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia Diammonium Glycyrrhizinate Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Diammonium Glycyrrhizinate Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Diammonium Glycyrrhizinate Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia Diammonium Glycyrrhizinate Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA Diammonium Glycyrrhizinate Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA Diammonium Glycyrrhizinate Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA Diammonium Glycyrrhizinate Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA Diammonium Glycyrrhizinate Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA Diammonium Glycyrrhizinate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA Diammonium Glycyrrhizinate Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA Diammonium Glycyrrhizinate Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Diammonium Glycyrrhizinate Image Figure 2. Global Diammonium Glycyrrhizinate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diammonium Glycyrrhizinate Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Capsule Image Figure 6. Global Diammonium Glycyrrhizinate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Diammonium Glycyrrhizinate Market Size Share 2021 VS 2025 VS 2032 Figure 8. Chronic Viral Hepatitis Image Figure 9. Immune Regulation Image Figure 10. Global Diammonium Glycyrrhizinate Market Size (US$ Million) & (2021-2032) Figure 11. Global Diammonium Glycyrrhizinate Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Diammonium Glycyrrhizinate Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Diammonium Glycyrrhizinate Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Diammonium Glycyrrhizinate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Diammonium Glycyrrhizinate Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Diammonium Glycyrrhizinate Revenue Market Share by Type (2021-2032) Figure 18. Global Diammonium Glycyrrhizinate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Diammonium Glycyrrhizinate Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Diammonium Glycyrrhizinate Revenue Market Share by Application (2021-2032) Figure 21. North America Diammonium Glycyrrhizinate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032) Figure 23. North America Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032) Figure 24. North America Diammonium Glycyrrhizinate Revenue Share by Country (2021-2032) Figure 25. United States Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Diammonium Glycyrrhizinate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032) Figure 30. Europe Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032) Figure 31. Europe Diammonium Glycyrrhizinate Revenue Share by Country (2021-2032) Figure 32. Germany Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Diammonium Glycyrrhizinate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032) Figure 42. China Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032) Figure 43. Asia Diammonium Glycyrrhizinate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032) Figure 45. Asia Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032) Figure 46. Asia Diammonium Glycyrrhizinate Revenue Share by Region (2021-2032) Figure 47. Japan Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Diammonium Glycyrrhizinate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032) Figure 55. SAMEA Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032) Figure 56. SAMEA Diammonium Glycyrrhizinate Revenue Share by Country (2021-2032) Figure 57. Brazil Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Diammonium Glycyrrhizinate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Capsule
Applications
  • Chronic Viral Hepatitis
  • Immune Regulation
Companies covered
  • Chia Tai Tianqing Pharmaceutical Group Co. Ltd
  • Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
  • Suzhou Erye Pharmaceutical Co. Ltd
  • Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
  • Jiangsu Tiansheng Pharmaceutical Co. Ltd
  • Sinopharm Guorui Pharmaceutical Co. Ltd
  • ND Pharma & Biotech Co. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Diammonium Glycyrrhizinate Market by Type
  3. 1.2.1 Global Diammonium Glycyrrhizinate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Capsule
  6. 1.3 Diammonium Glycyrrhizinate Market by Application
  7. 1.3.1 Global Diammonium Glycyrrhizinate Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Chronic Viral Hepatitis
  9. 1.3.3 Immune Regulation
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Diammonium Glycyrrhizinate Market Dynamics
  1. 2.1 Diammonium Glycyrrhizinate Industry Trends
  2. 2.2 Diammonium Glycyrrhizinate Industry Drivers
  3. 2.3 Diammonium Glycyrrhizinate Industry Opportunities and Challenges
  4. 2.4 Diammonium Glycyrrhizinate Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Diammonium Glycyrrhizinate Market Perspective (2021-2032)
  2. 3.2 Global Diammonium Glycyrrhizinate Growth Trends by Region
  3. 3.2.1 Global Diammonium Glycyrrhizinate Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Diammonium Glycyrrhizinate Market Size by Region (2021-2026)
  5. 3.2.3 Global Diammonium Glycyrrhizinate Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Diammonium Glycyrrhizinate Revenue by Players
  2. 4.1.1 Global Diammonium Glycyrrhizinate Revenue by Players (2021-2026)
  3. 4.1.2 Global Diammonium Glycyrrhizinate Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Diammonium Glycyrrhizinate Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Diammonium Glycyrrhizinate Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Diammonium Glycyrrhizinate Key Players Headquarters & Area Served
  7. 4.4 Global Diammonium Glycyrrhizinate Players, Product Type & Application
  8. 4.5 Global Diammonium Glycyrrhizinate Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Diammonium Glycyrrhizinate Market CR5 and HHI
  11. 4.6.3 2025 Diammonium Glycyrrhizinate Tier 1, Tier 2, and Tier 3
5 Diammonium Glycyrrhizinate Market Size by Type
  1. 5.1 Global Diammonium Glycyrrhizinate Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Diammonium Glycyrrhizinate Revenue by Type (2021-2032)
  3. 5.3 Global Diammonium Glycyrrhizinate Revenue Market Share by Type (2021-2032)
6 Diammonium Glycyrrhizinate Market Size by Application
  1. 6.1 Global Diammonium Glycyrrhizinate Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Diammonium Glycyrrhizinate Revenue by Application (2021-2032)
  3. 6.3 Global Diammonium Glycyrrhizinate Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd
  2. 7.1.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Company Information
  3. 7.1.2 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Business Overview
  4. 7.1.3 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  6. 7.1.5 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Recent Developments
  7. 7.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
  8. 7.2.1 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Company Information
  9. 7.2.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Business Overview
  10. 7.2.3 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  12. 7.2.5 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Recent Developments
  13. 7.3 Suzhou Erye Pharmaceutical Co. Ltd
  14. 7.3.1 Suzhou Erye Pharmaceutical Co. Ltd Company Information
  15. 7.3.2 Suzhou Erye Pharmaceutical Co. Ltd Business Overview
  16. 7.3.3 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  18. 7.3.5 Suzhou Erye Pharmaceutical Co. Ltd Recent Developments
  19. 7.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
  20. 7.4.1 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Company Information
  21. 7.4.2 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Business Overview
  22. 7.4.3 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Product Portfolio
  24. 7.4.5 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Recent Developments
  25. 7.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd
  26. 7.5.1 Jiangsu Tiansheng Pharmaceutical Co. Ltd Company Information
  27. 7.5.2 Jiangsu Tiansheng Pharmaceutical Co. Ltd Business Overview
  28. 7.5.3 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  30. 7.5.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd Recent Developments
  31. 7.6 Sinopharm Guorui Pharmaceutical Co. Ltd
  32. 7.6.1 Sinopharm Guorui Pharmaceutical Co. Ltd Company Information
  33. 7.6.2 Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview
  34. 7.6.3 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
  36. 7.6.5 Sinopharm Guorui Pharmaceutical Co. Ltd Recent Developments
  37. 7.7 ND Pharma & Biotech Co. Ltd.
  38. 7.7.1 ND Pharma & Biotech Co. Ltd. Company Information
  39. 7.7.2 ND Pharma & Biotech Co. Ltd. Business Overview
  40. 7.7.3 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Product Portfolio
  42. 7.7.5 ND Pharma & Biotech Co. Ltd. Recent Developments
8 North America
  1. 8.1 North America Diammonium Glycyrrhizinate Revenue (2021-2032)
  2. 8.2 North America Diammonium Glycyrrhizinate Revenue by Type (2021-2032)
  3. 8.2.1 North America Diammonium Glycyrrhizinate Revenue by Type (2021-2026)
  4. 8.2.2 North America Diammonium Glycyrrhizinate Revenue by Type (2027-2032)
  5. 8.3 North America Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032)
  6. 8.4 North America Diammonium Glycyrrhizinate Revenue by Application (2021-2032)
  7. 8.4.1 North America Diammonium Glycyrrhizinate Revenue by Application (2021-2026)
  8. 8.4.2 North America Diammonium Glycyrrhizinate Revenue by Application (2027-2032)
  9. 8.5 North America Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032)
  10. 8.6 North America Diammonium Glycyrrhizinate Revenue by Country
  11. 8.6.1 North America Diammonium Glycyrrhizinate Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Diammonium Glycyrrhizinate Revenue by Country (2021-2026)
  13. 8.6.3 North America Diammonium Glycyrrhizinate Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Diammonium Glycyrrhizinate Revenue (2021-2032)
  2. 9.2 Europe Diammonium Glycyrrhizinate Revenue by Type (2021-2032)
  3. 9.2.1 Europe Diammonium Glycyrrhizinate Revenue by Type (2021-2026)
  4. 9.2.2 Europe Diammonium Glycyrrhizinate Revenue by Type (2027-2032)
  5. 9.3 Europe Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032)
  6. 9.4 Europe Diammonium Glycyrrhizinate Revenue by Application (2021-2032)
  7. 9.4.1 Europe Diammonium Glycyrrhizinate Revenue by Application (2021-2026)
  8. 9.4.2 Europe Diammonium Glycyrrhizinate Revenue by Application (2027-2032)
  9. 9.5 Europe Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032)
  10. 9.6 Europe Diammonium Glycyrrhizinate Revenue by Country
  11. 9.6.1 Europe Diammonium Glycyrrhizinate Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Diammonium Glycyrrhizinate Revenue by Country (2021-2026)
  13. 9.6.3 Europe Diammonium Glycyrrhizinate Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Diammonium Glycyrrhizinate Revenue (2021-2032)
  2. 10.2 China Diammonium Glycyrrhizinate Revenue by Type (2021-2032)
  3. 10.2.1 China Diammonium Glycyrrhizinate Revenue by Type (2021-2026)
  4. 10.2.2 China Diammonium Glycyrrhizinate Revenue by Type (2027-2032)
  5. 10.3 China Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032)
  6. 10.4 China Diammonium Glycyrrhizinate Revenue by Application (2021-2032)
  7. 10.4.1 China Diammonium Glycyrrhizinate Revenue by Application (2021-2026)
  8. 10.4.2 China Diammonium Glycyrrhizinate Revenue by Application (2027-2032)
  9. 10.5 China Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Diammonium Glycyrrhizinate Revenue (2021-2032)
  2. 11.2 Asia Diammonium Glycyrrhizinate Revenue by Type (2021-2032)
  3. 11.2.1 Asia Diammonium Glycyrrhizinate Revenue by Type (2021-2026)
  4. 11.2.2 Asia Diammonium Glycyrrhizinate Revenue by Type (2027-2032)
  5. 11.3 Asia Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032)
  6. 11.4 Asia Diammonium Glycyrrhizinate Revenue by Application (2021-2032)
  7. 11.4.1 Asia Diammonium Glycyrrhizinate Revenue by Application (2021-2026)
  8. 11.4.2 Asia Diammonium Glycyrrhizinate Revenue by Application (2027-2032)
  9. 11.5 Asia Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032)
  10. 11.6 Asia Diammonium Glycyrrhizinate Revenue by Country
  11. 11.6.1 Asia Diammonium Glycyrrhizinate Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Diammonium Glycyrrhizinate Revenue by Country (2021-2026)
  13. 11.6.3 Asia Diammonium Glycyrrhizinate Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Diammonium Glycyrrhizinate Revenue (2021-2032)
  2. 12.2 SAMEA Diammonium Glycyrrhizinate Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Diammonium Glycyrrhizinate Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Diammonium Glycyrrhizinate Revenue by Type (2027-2032)
  5. 12.3 SAMEA Diammonium Glycyrrhizinate Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Diammonium Glycyrrhizinate Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Diammonium Glycyrrhizinate Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Diammonium Glycyrrhizinate Revenue by Application (2027-2032)
  9. 12.5 SAMEA Diammonium Glycyrrhizinate Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Diammonium Glycyrrhizinate Revenue by Country
  11. 12.6.1 SAMEA Diammonium Glycyrrhizinate Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Diammonium Glycyrrhizinate Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Diammonium Glycyrrhizinate Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst